SAD and MAD Study of FTX-101 in Healthy Male Subjects

NCT06617546 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
49
Enrollment
INDUSTRY
Sponsor class

Stopped Study's goals have been achieved based on a preliminary analysis of available pharmacokinetic and safety data, which demonstrate that sufficient information has been obtained.

Conditions

Interventions

Sponsor

Find Therapeutics